BMA
JNJ icon

Brooks Moore & Associates’s Johnson & Johnson JNJ Stock Holding History

Brooks Moore & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.78M Sell
31,826
-3,241
-9% -$755K 3.9% 2
2025
Q4 		$7.26M Sell
35,067
-171
-0.5% -$33.8K 3.57% 5
2025
Q3 		$6.53M Sell
35,238
-477
-1% -$81.7K 3.31% 5
2025
Q2 		$5.88M Buy
35,715
+254
+0.7% +$39K 3.18% 5
2025
Q1 		$5.88M Sell
35,461
-226
-0.6% -$35.4K 3.32% 5
2024
Q4 		$5.16M Buy
35,687
+932
+3% +$144K 3.05% 5
2024
Q3 		$5.63M Sell
34,755
-266
-0.8% -$42.4K 3.33% 6
2024
Q2 		$5.12M Buy
35,021
+449
+1% +$66.8K 3.29% 7
2024
Q1 		$5.47M Buy
34,572
+13
+0% +$2.07K 3.51% 6
2023
Q4 		$5.42M Sell
34,559
-328
-0.9% -$50.3K 3.72% 3
2023
Q3 		$5.43M Sell
34,887
-794
-2% -$131K 4.1% 3
2023
Q2 		$5.91M Sell
35,681
-75
-0.2% -$12.1K 4.16% 2
2023
Q1 		$5.54M Buy
35,756
+3,071
+9% +$496K 3.98% 3
2022
Q4 		$5.77M Buy
32,685
+249
+0.8% +$43K 4.22% 1
2022
Q3 		$5.3M Buy
32,436
+2,495
+8% +$422K 4.29% 1
2022
Q2 		$5.32M Sell
29,941
-195
-0.6% -$34.7K 3.83% 3
2022
Q1 		$5.34M Buy
30,136
+325
+1% +$55.3K 3.28% 4
2021
Q4 		$5.1M Sell
29,811
-233
-0.8% -$38.1K 2.99% 5
2021
Q3 		$4.85M Buy
30,044
+150
+0.5% +$25.6K 3.17% 3
2021
Q2 		$4.92M Buy
29,894
+44
+0.1% +$7.28K 3.14% 4
2021
Q1 		$4.91M Buy
29,850
+628
+2% +$102K 3.32% 3
2020
Q4 		$4.6M Sell
29,222
-85
-0.3% -$12.5K 3.56% 3
2020
Q3 		$4.36M Buy
29,307
+544
+2% +$80.5K 3.76% 3
2020
Q2 		$4.04M Sell
28,763
-2,565
-8% -$374K 3.79% 4
2020
Q1 		$4.11M Sell
31,328
-495
-2% -$70.2K 4.36% 3
2019
Q4 		$4.64M Sell
31,823
-125
-0.4% -$17K 3.68% 3
2019
Q3 		$4.13M Buy
31,948
+771
+2% +$102K 3.49% 3
2019
Q2 		$4.34M Sell
31,177
-210
-0.7% -$29.1K 3.73% 3
2019
Q1 		$4.39M Hold
31,387
– – 4% 2
2018
Q4 		$4.05M Buy
+31,387
New +$4.38M 4.08% 2

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brooks Moore & Associates's JNJ Position: Q1 2026 in Review

Brooks Moore & Associates reduced its Johnson & Johnson (JNJ) stake by 9.2% in Q1 2026, selling an estimated $755K and leaving 31,826 shares worth $7.78M. The position accounts for 3.9% of the portfolio, ranked #2.

Brooks Moore & Associates first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Brooks Moore & Associates held 31,826 shares of Johnson & Johnson worth $7.78M as of Q1 2026.
  • Brooks Moore & Associates sold 3,241 Johnson & Johnson shares in Q1 2026, an estimated $755K.
  • Johnson & Johnson made up 3.9% of Brooks Moore & Associates's portfolio in Q1 2026, its #2 holding.
  • Brooks Moore & Associates first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Brooks Moore & Associates's 13F filing for Q1 2026, filed 15 May 2026.